Robert M Kunemund
Examiner (ID: 4089)
Most Active Art Unit | 1714 |
Art Unit(s) | 1107, 1765, 1714, 1792, 1722, 1109, 1103, 1763 |
Total Applications | 3442 |
Issued Applications | 2671 |
Pending Applications | 149 |
Abandoned Applications | 593 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12030818
[patent_doc_number] => 20170320917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway'
[patent_app_type] => utility
[patent_app_number] => 15/628771
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22668
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15628771
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/628771 | Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway | Jun 20, 2017 | Abandoned |
Array
(
[id] => 14169143
[patent_doc_number] => 10258557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Peptide for stimulating melanogenesis
[patent_app_type] => utility
[patent_app_number] => 15/626891
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 2287
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626891
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/626891 | Peptide for stimulating melanogenesis | Jun 18, 2017 | Issued |
Array
(
[id] => 14088061
[patent_doc_number] => 10239924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-26
[patent_title] => Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells
[patent_app_type] => utility
[patent_app_number] => 15/624906
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 4084
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/624906 | Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells | Jun 15, 2017 | Issued |
Array
(
[id] => 14652687
[patent_doc_number] => 20190233472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => NOVEL TRIPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/309641
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309641
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309641 | Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof | Jun 15, 2017 | Issued |
Array
(
[id] => 15267423
[patent_doc_number] => 20190382445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => PEPTIDE HAVING MELANOGENESIS-INHIBITING ACTIVITY AND COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 16/308410
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308410
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308410 | PEPTIDE HAVING MELANOGENESIS-INHIBITING ACTIVITY AND COMPOSITION COMPRISING SAME | Jun 8, 2017 | Abandoned |
Array
(
[id] => 11977587
[patent_doc_number] => 20170281742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'H3.3 CTL Peptides and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/613837
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18660
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613837
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/613837 | H3.3 CTL peptides and uses thereof | Jun 4, 2017 | Issued |
Array
(
[id] => 12092536
[patent_doc_number] => 20170349629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'Angiotensin-1-Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 15/612763
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10510
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/612763 | Angiotensin-1-receptor antagonists | Jun 1, 2017 | Issued |
Array
(
[id] => 11963569
[patent_doc_number] => 20170267722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'INHIBITORY PEPTIDES OF VIRAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/605877
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19647
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605877
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/605877 | Inhibitory peptides of viral infection | May 24, 2017 | Issued |
Array
(
[id] => 14497927
[patent_doc_number] => 20190192618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => SPR741 HUMAN PHARMACOKINETICS AND EFFICACIOUS DOSE
[patent_app_type] => utility
[patent_app_number] => 16/301355
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301355 | SPR741 HUMAN PHARMACOKINETICS AND EFFICACIOUS DOSE | May 14, 2017 | Abandoned |
Array
(
[id] => 11992465
[patent_doc_number] => 20170296620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'BIS-SULFHYDRYL MACROCYCLIZATION SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 15/592517
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18962
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15592517
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/592517 | Bis-sulfhydryl macrocyclization systems | May 10, 2017 | Issued |
Array
(
[id] => 16304158
[patent_doc_number] => 10772929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Use of peptide compounds in treating acute pancreatitis
[patent_app_type] => utility
[patent_app_number] => 16/094881
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 6349
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094881
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094881 | Use of peptide compounds in treating acute pancreatitis | May 10, 2017 | Issued |
Array
(
[id] => 14581289
[patent_doc_number] => 20190218253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Therapeutic SALL4 Peptide
[patent_app_type] => utility
[patent_app_number] => 16/095603
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095603
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095603 | Therapeutic spalt-like transcription factor 4 (SALL4) peptide | Apr 27, 2017 | Issued |
Array
(
[id] => 16498886
[patent_doc_number] => 10864253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage
[patent_app_type] => utility
[patent_app_number] => 16/096247
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29982
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096247
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096247 | Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage | Apr 27, 2017 | Issued |
Array
(
[id] => 16105391
[patent_doc_number] => 10695279
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Peptide having skin-whitening activity and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/554067
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 5747
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554067
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554067 | Peptide having skin-whitening activity and use thereof | Apr 26, 2017 | Issued |
Array
(
[id] => 11866159
[patent_doc_number] => 20170233445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'ANTI-MICROBIAL PEPTIDE AND METHOD FOR TREATING MICROBIAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/498482
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8416
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498482
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498482 | Anti-microbial peptide and method for treating microbial infection | Apr 26, 2017 | Issued |
Array
(
[id] => 11979314
[patent_doc_number] => 20170283468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'PEPTIDES FOR DIAGNOSIS AND TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/497851
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10346
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15497851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/497851 | Peptides for diagnosis and treatment of cancer | Apr 25, 2017 | Issued |
Array
(
[id] => 14868009
[patent_doc_number] => 20190284246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PEPTIDE INHIBITING COLONIZATION BY PATHOGENIC BACTERIA, AND COLONIZATION INHIBITOR INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 16/097219
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097219
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097219 | Peptide inhibiting colonization by pathogenic bacteria, and colonization inhibitor including same | Apr 24, 2017 | Issued |
Array
(
[id] => 11852044
[patent_doc_number] => 20170226537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'ALCOHOL PRODUCT PROCESSES'
[patent_app_type] => utility
[patent_app_number] => 15/495027
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13720
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495027
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/495027 | ALCOHOL PRODUCT PROCESSES | Apr 23, 2017 | Abandoned |
Array
(
[id] => 11993944
[patent_doc_number] => 20170298099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES'
[patent_app_type] => utility
[patent_app_number] => 15/493301
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 36765
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/493301 | BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES | Apr 20, 2017 | Abandoned |
Array
(
[id] => 12001816
[patent_doc_number] => 20170305971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'POTENT COMPSTATIN ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 15/490437
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14463
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490437
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490437 | POTENT COMPSTATIN ANALOGS | Apr 17, 2017 | Abandoned |